| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.2 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.079 | 0.2 |